Orf virus interferes with MHC class I surface expression by targeting vesicular transport and Golgi

BMC Veterinary Research

Volumn 8, Issue , 2012, Pages

  Rohde, Jörg ^a,b   Emschermann, Frederic ^b   Knittler, Michael R ^b   Rziha, Hanns Joachim ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

Author keywords

Golgi apparatus; Immunomodulation; MHC class I; Orf virus; Parapoxvirus; Subversion

Indexed keywords

BOVIDAE; CAPRA HIRCUS; ORF VIRUS; OVIS ARIES; PARAPOXVIRUS; POXVIRIDAE;

MONOCLONAL ANTIBODY;

ANIMAL; ARTICLE; CERCOPITHECUS; CONTAGIOUS ECTHYMA; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE; GENE EXPRESSION REGULATION; GENETICS; GOLGI COMPLEX; PHYSIOLOGY; POXVIRUS; PROTEIN TRANSPORT; VERO CELL; VIROLOGY;

ANIMALS; ANTIBODIES, MONOCLONAL; CERCOPITHECUS AETHIOPS; ECTHYMA, CONTAGIOUS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENES, MHC CLASS I; GOLGI APPARATUS; ORF VIRUS; PROTEIN TRANSPORT; VERO CELLS;

EID: 84866183267     PISSN: None     EISSN: 17466148     Source Type: Journal    
DOI: 10.1186/1746-6148-8-114     Document Type: Article

References (41)

1. Büttner M, Rziha HJ. Parapoxviruses: from the lesion to the viral genome. J Vet Med B Infect Dis Vet Public Health 2002, 49(1):7-16. 10.1046/j.1439-0450.2002.00539.x, 11911596.
2. Haig DM. Orf virus infection and host immunity. Curr Opin Infect Dis 2006, 19(2):127-131. 10.1097/01.qco.0000216622.75326.ef, 16514336.
3. Seet BT, Johnston JB, Brunetti CR, Barrett JW, Everett H, Cameron C, Sypula J, Nazarian SH, Lucas A, McFadden G. Poxviruses and immune evasion. Annu Rev Immunol 2003, 21:377-423. 10.1146/annurev.immunol.21.120601.141049, 12543935.
4. Fleming SB, McCaughan CA, Andrews AE, Nash AD, Mercer AA. A homolog of interleukin-10 is encoded by the poxvirus orf virus. J Virol 1997, 71(6):4857-4861. 191714, 9151886.
5. McInnes CJ, Wood AR, Mercer AA. Orf virus encodes a homolog of the vaccinia virus interferon-resistance gene E3L. Virus Genes 1998, 17(2):107-115. 10.1023/A:1026431704679, 9857983.
6. Deane D, McInnes CJ, Percival A, Wood A, Thomson J, Lear A, Gilray J, Fleming S, Mercer A, Haig D. Orf virus encodes a novel secreted protein inhibitor of granulocyte-macrophage colony-stimulating factor and interleukin-2. J Virol 2000, 74(3):1313-1320. 10.1128/JVI.74.3.1313-1320.2000, 111466, 10627542.
7. Imlach W, McCaughan CA, Mercer AA, Haig D, Fleming SB. Orf virus-encoded interleukin-10 stimulates the proliferation of murine mast cells and inhibits cytokine synthesis in murine peritoneal macrophages. J Gen Virol 2002, 83(Pt 5):1049-1058.
8. Lateef Z, Baird MA, Wise LM, Young S, Mercer AA, Fleming SB. The chemokine-binding protein encoded by the poxvirus orf virus inhibits recruitment of dendritic cells to sites of skin inflammation and migration to peripheral lymph nodes. Cell Microbiol 2010, 12(5):665-676. 10.1111/j.1462-5822.2009.01425.x, 20039877.
9. Abendroth A, Arvin A. Immune evasion mechanisms of varicella-zoster virus. Arch Virol Suppl 2001, 17:99-107.
10. Williams DB, Vassilakos A, Suh WK. Peptide presentation by MHC class I molecules. Trends Cell Biol 1996, 6(7):267-273. 10.1016/0962-8924(96)10020-9, 15157453.
11. Ambagala AP, Solheim JC, Srikumaran S. Viral interference with MHC class I antigen presentation pathway: the battle continues. Vet Immunol Immunopathol 2005, 107(1-2):1-15.
12. Hewitt EW. The MHC class I antigen presentation pathway: strategies for viral immune evasion. Immunology 2003, 110(2):163-169. 10.1046/j.1365-2567.2003.01738.x, 1783040, 14511229.
13. Heemels MT, Ploegh H. Generation, translocation, and presentation of MHC class I-restricted peptides. Annu Rev Biochem 1995, 64:463-491. 10.1146/annurev.bi.64.070195.002335, 7574490.
14. Jonjic S, Babic M, Polic B, Krmpotic A. Immune evasion of natural killer cells by viruses. Curr Opin Immunol 2008, 20(1):30-38. 10.1016/j.coi.2007.11.002, 2700287, 18206359.
15. Zuniga MC, Wang H, Barry M, McFadden G. Endosomal/lysosomal retention and degradation of major histocompatibility complex class I molecules is induced by myxoma virus. Virology 1999, 261(2):180-192. 10.1006/viro.1999.9840, 10497104.
16. Byun M, Wang X, Pak M, Hansen TH, Yokoyama WM. Cowpox virus exploits the endoplasmic reticulum retention pathway to inhibit MHC class I transport to the cell surface. Cell Host Microbe 2007, 2(5):306-315. 10.1016/j.chom.2007.09.002, 18005752.
17. Dasgupta A, Hammarlund E, Slifka MK, Fruh K. Cowpox virus evades CTL recognition and inhibits the intracellular transport of MHC class I molecules. J Immunol 2007, 178(3):1654-1661.
18. Byun M, Verweij MC, Pickup DJ, Wiertz EJ, Hansen TH, Yokoyama WM. Two mechanistically distinct immune evasion proteins of cowpox virus combine to avoid antiviral CD8 T cells. Cell Host Microbe 2009, 6(5):422-432. 10.1016/j.chom.2009.09.012, 2791900, 19917497.
19. Alzhanova D, Edwards DM, Hammarlund E, Scholz IG, Horst D, Wagner MJ, Upton C, Wiertz EJ, Slifka MK, Fruh K. Cowpox virus inhibits the transporter associated with antigen processing to evade T cell recognition. Cell Host Microbe 2009, 6(5):433-445. 10.1016/j.chom.2009.09.013, 2791678, 19917498.
20. Traub LM, Bannykh SI, Rodel JE, Aridor M, Balch WE, Kornfeld S. AP-2-containing clathrin coats assemble on mature lysosomes. J Cell Biol 1996, 135(6 Pt 2):1801-1814. 2133961, 8991092.
21. Rabouille C, Klumperman J. Opinion: The maturing role of COPI vesicles in intra-Golgi transport. Nat Rev Mol Cell Biol 2005, 6(10):812-817. 10.1038/nrm1735, 16167055.
22. Lowe M, Kreis TE. In vivo assembly of coatomer, the COP-I coat precursor. J Biol Chem 1996, 271(48):30725-30730. 10.1074/jbc.271.48.30725, 8940050.
23. Abendroth A, Lin I, Slobedman B, Ploegh H, Arvin AM. Varicella-zoster virus retains major histocompatibility complex class I proteins in the Golgi compartment of infected cells. J Virol 2001, 75(10):4878-4888. 10.1128/JVI.75.10.4878-4888.2001, 114242, 11312359.
24. Campadelli G, Brandimarti R, Di Lazzaro C, Ward PL, Roizman B, Torrisi MR. Fragmentation and dispersal of Golgi proteins and redistribution of glycoproteins and glycolipids processed through the Golgi apparatus after infection with herpes simplex virus 1. Proc Natl Acad Sci U S A 1993, 90(7):2798-2802. 10.1073/pnas.90.7.2798, 46183, 8385343.
25. Quiner CA, Jackson WT. Fragmentation of the Golgi apparatus provides replication membranes for human rhinovirus 1A. Virology 2010, 407(2):185-195. 10.1016/j.virol.2010.08.012, 20825962.
26. Sandoval IV, Carrasco L. Poliovirus infection and expression of the poliovirus protein 2B provoke the disassembly of the Golgi complex, the organelle target for the antipoliovirus drug Ro-090179. J Virol 1997, 71(6):4679-4693. 191690, 9151862.
27. Beske O, Reichelt M, Taylor MP, Kirkegaard K, Andino R. Poliovirus infection blocks ERGIC-to-Golgi trafficking and induces microtubule-dependent disruption of the Golgi complex. J Cell Sci 2007, 120(Pt 18):3207-3218.
28. Schmelz M, Sodeik B, Ericsson M, Wolffe EJ, Shida H, Hiller G, Griffiths G. Assembly of vaccinia virus: the second wrapping cisterna is derived from the trans Golgi network. J Virol 1994, 68(1):130-147. 236272, 8254722.
29. Tan JL, Ueda N, Mercer AA, Fleming SB. Investigation of orf virus structure and morphogenesis using recombinants expressing FLAG-tagged envelope structural proteins: evidence for wrapped virus particles and egress from infected cells. J Gen Virol 2009, 90(Pt 3):614-625.
30. Ashrafi GH, Haghshenas MR, Marchetti B, O'Brien PM, Campo MS. E5 protein of human papillomavirus type 16 selectively downregulates surface HLA class I. Int J Cancer 2005, 113(2):276-283. 10.1002/ijc.20558, 15386416.
31. Girod A, Storrie B, Simpson JC, Johannes L, Goud B, Roberts LM, Lord JM, Nilsson T, Pepperkok R. Evidence for a COP-I-independent transport route from the Golgi complex to the endoplasmic reticulum. Nat Cell Biol 1999, 1(7):423-430. 10.1038/15658, 10559986.
32. Kirchhausen T. Three ways to make a vesicle. Nat Rev Mol Cell Biol 2000, 1(3):187-198. 10.1038/35043117, 11252894.
33. Pierini R, Cottam E, Roberts R, Wileman T. Modulation of membrane traffic between endoplasmic reticulum, ERGIC and Golgi to generate compartments for the replication of bacteria and viruses. Semin Cell Dev Biol 2009, 20(7):828-833. 10.1016/j.semcdb.2009.03.015, 19508853.
34. Zhang L, Lee SY, Beznoussenko GV, Peters PJ, Yang JS, Gilbert HY, Brass AL, Elledge SJ, Isaacs SN, Moss B, et al. A role for the host coatomer and KDEL receptor in early vaccinia biogenesis. Proc Natl Acad Sci U S A 2009, 106(1):163-168. 10.1073/pnas.0811631106, 2629213, 19109439.
35. Yilla M, Tan A, Ito K, Miwa K, Ploegh HL. Involvement of the vacuolar H(+)-ATPases in the secretory pathway of HepG2 cells. J Biol Chem 1993, 268(25):19092-19100.
36. Fischer T, Planz O, Stitz L, Rziha HJ. Novel recombinant parapoxvirus vectors induce protective humoral and cellular immunity against lethal herpesvirus challenge infection in mice. J Virol 2003, 77(17):9312-9323. 10.1128/JVI.77.17.9312-9323.2003, 187421, 12915547.
37. Brodsky FM, Parham P. Evolution of HLA antigenic determinants: species cross-reactions of monoclonal antibodies. Immunogenetics 1982, 15(2):151-166. 10.1007/BF00621948, 6174442.
38. Housawi FM, Roberts GM, Gilray JA, Pow I, Reid HW, Nettleton PF, Sumption KJ, Hibma MH, Mercer AA. The reactivity of monoclonal antibodies against orf virus with other parapoxviruses and the identification of a 39 kDa immunodominant protein. Arch Virol 1998, 143(12):2289-2303. 10.1007/s007050050461, 9930187.
39. Fischer T, Büttner M, Rziha HJ. T helper 1-type cytokine transcription in peripheral blood mononuclear cells of pseudorabies virus (Suid herpesvirus 1)-primed swine indicates efficient immunization. Immunology 2000, 101(3):378-387. 10.1046/j.1365-2567.2000.00124.x, 2327083, 11106942.
40. Ashrafi GH, Tsirimonaki E, Marchetti B, O'Brien PM, Sibbet GJ, Andrew L, Campo MS. Down-regulation of MHC class I by bovine papillomavirus E5 oncoproteins. Oncogene 2002, 21(2):248-259. 10.1038/sj.onc.1205008, 11803468.
41. Henkel M, Planz O, Fischer T, Stitz L, Rziha HJ. Prevention of virus persistence and protection against immunopathology after Borna disease virus infection of the brain by a novel Orf virus recombinant. J Virol 2005, 79(1):314-325. 10.1128/JVI.79.1.314-325.2005, 538698, 15596826.